Evifacotrep, a short transient receptor potential channel 5 and 4 (TRPC5/TRPC4) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases. Evifacotrep targets to TRPC5/TRPC4 with IC50s 50 nM[1].
Molecular Weight:
441.77
Purity:
99.55
CAS Number:
[2413739-88-3]
Formula:
C18H12ClF4N5O2
Target:
TRP Channel
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted